Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence and Clinicopathological Characteristics of Moderate and High-Penetrance Genes in Non-BRCA1/2 Breast Cancer High-Risk Spanish Families. | J Pers Med | 2021 | 34204722 | PubTator, text mining | PubMed |
| Targeted Sequencing of Taiwanese Breast Cancer with Risk Stratification by the Concurrent Genes Signature: A Feasibility Study. | J Pers Med | 2021 | 34203389 | PubTator, text mining | PubMed |
| PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening. | Biomedicines | 2021 | 34203351 | PubTator, text mining | PubMed |
| BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer. | Genes (Basel) | 2021 | 34201956 | PubTator, text mining | PubMed |
| Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. | Int J Mol Sci | 2021 | 34200975 | PubTator, text mining | PubMed |
| Molecular Characterization of Muellerian Tumors of the Urinary Tract. | Genes (Basel) | 2021 | 34200508 | PubTator, text mining | PubMed |
| Therapy Development by Genome Editing of Hematopoietic Stem Cells. | Cells | 2021 | 34198536 | PubTator, text mining | PubMed |
| DNA Damage Repair Gene Set as a Potential Biomarker for Stratifying Patients with High Tumor Mutational Burden. | Biology (Basel) | 2021 | 34198473 | PubTator, text mining | PubMed |
| EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart. | Mol Cell | 2021 | 34197737 | PubTator, text mining | PubMed |
| PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair. | Nucleic Acids Res | 2021 | 34197606 | PubTator, text mining | PubMed |
| Metastatic Prostate Cancer Synchronous with Male Breast Papillary Ductal Carcinoma in situ: Management Dilemma and Literature Review. | Case Rep Oncol | 2021 | 34177531 | PubTator, text mining | PubMed |
| Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer. | Cancer Med | 2021 | 34173341 | PubTator, text mining | PubMed |
| Molecular landscape of head and neck cancer and implications for therapy. | Ann Transl Med | 2021 | 34164549 | PubTator, text mining | PubMed |
| Current controversies and advances in the management of pancreatic adenocarcinoma. | World J Gastrointest Oncol | 2021 | 34163568 | PubTator, text mining | PubMed |
| Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience. | Medicine (Baltimore) | 2021 | 34160418 | PubTator, text mining | PubMed |
| Museomics Dissects the Genetic Basis for Adaptive Seasonal Coloration in the Least Weasel. | Mol Biol Evol | 2021 | 34157721 | PubTator, text mining | PubMed |
| Searching for female reproductive aging and longevity biomarkers. | Aging (Albany NY) | 2021 | 34156973 | PubTator, text mining | PubMed |
| CRISPR-Cas9 Editing of Human Histone Deubiquitinase Gene USP16 in Human Monocytic Leukemia Cell Line THP-1. | Front Cell Dev Biol | 2021 | 34136489 | PubTator, text mining | PubMed |
| Modifying splice site usage with ModCon: Maintaining the genetic code while changing the underlying mRNP code. | Comput Struct Biotechnol J | 2021 | 34136105 | PubTator, text mining | PubMed |
| Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden. | BMC Cancer | 2021 | 34130653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=69